...
首页> 外文期刊>American journal of therapeutics >Safety and Efficacy of Dexmedetomidine as a Sedative Agent for Performing Awake Intubation: A Meta-analysis
【24h】

Safety and Efficacy of Dexmedetomidine as a Sedative Agent for Performing Awake Intubation: A Meta-analysis

机译:右美托咪定作为清醒插管镇静剂的安全性和有效性:荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

To compare the efficacy and safety of dexmedetomidine with other alternative sedative agents used for performing awake intubation. We conducted a meta-analysis of randomized controlled trials (RCTs) that compared the effects of dexmedetomidine with other alternative sedative agents used during awake intubation. The biomedical databases PubMed, Science Direct, and the Cochrane Library were searched for relevant RCTs with no restriction on the language of publication. The efficacy (level of sedation, success rate for intubation at the first attempt, intubation time, intubation conditions, and patient satisfaction) and safety (incidence of hypertension, hypotension, tachycardia, bradycardia, hypoxia, postsurgical memory, hoarseness, and sore throat) were assessed. Thirteen RCTs with a combined subject population of 591 patients came within the purview of this meta-analysis. Use of dexmedetomidine was associated with a higher Ramsay sedation scale score [mean difference (MD): 1.02, 95% confidence interval (CI), 0.77-1.28, P < 0.00001], vocal cord movement score (MD = 0.72, 95% CI, 0.20-1.24, P = 0.007), coughing scores (MD = 0.66, 95% CI, 0.10-1.22, P = 0.02), limb movement scores (MD = 0.69, 95% CI, 0.47-0.91, P < 0.00001); increased risk of bradycardia [relative risk (RR): 3.03, 95% CI, 1.38-6.68, P = 0.006] and hypotension (RR: 2.87, 95% CI, 1.44-5.75, P = 0.003); and lower risk of hypoxia (RR: 0.32, 95% CI, 0.15-0.70; P = 0.004) and postsurgical memory (RR: 0.50, 95% CI, 0.35-0.72, P = 0.0002). As indicated by our results, dexmedetomidine appears to be an effective and well-tolerated agent for performing awake intubation. Its use was associated with better intubation conditions, preservation of airway patency, and reduced recall of intubation, as compared with the traditional sedative agents. The risk of bradycardia and hypotension was significantly higher with dexmedetomidine as compared with that with other sedatives. However, these were easily managed with atropine and vasoactive agents.
机译:为了比较右美托咪定与其他用于清醒插管的镇静剂的疗效和安全性。我们对随机对照试验(RCT)进行了荟萃分析,比较了右美托咪定与清醒插管期间使用的其他其他镇静剂的作用。在生物医学数据库PubMed,Science Direct和Cochrane图书馆中搜索相关的RCT,不受出版语言的限制。疗效(镇静水平,首次尝试插管成功率,插管时间,插管条件和患者满意度)和安全性(高血压,低血压,心动过速,心动过缓,缺氧,术后记忆,声音嘶哑和喉咙痛)被评估。这项荟萃分析的范围包括13项RCT,共591名患者。右美托咪定的使用与较高的Ramsay镇静评分有关[平均差异(MD):1.02,95%置信区间(CI),0.77-1.28,P <0.00001],声带运动评分(MD = 0.72,95%CI ,0.20-1.24,P = 0.007),咳嗽分数(MD = 0.66,95%CI,0.10-1.22,P = 0.02),肢体运动分数(MD = 0.69,95%CI,0.47-0.91,P <0.00001) ;心动过缓的风险增加[相对风险(RR):3.03,95%CI,1.38-6.68,P = 0.006]和低血压(RR:2.87,95%CI,1.44-5.75,P = 0.003);低氧风险(RR:0.32,95%CI,0.15-0.70; P = 0.004)和术后记忆(RR:0.50,95%CI,0.35-0.72,P = 0.0002)。如我们的结果所示,右美托咪定似乎是进行清醒插管的有效且耐受性良好的药物。与传统的镇静剂相比,它的使用与更好的插管条件,保持气道通畅和减少插管的召回率有关。与其他镇静剂相比,右美托咪定的心动过缓和低血压的风险明显更高。但是,使用阿托品和血管活性剂可以轻松解决这些问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号